Overview

Erythropoietin (EPO) to Protect Renal Function After Cardiac Surgery

Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the potential of erythropoietin in reducing risk and degree of acute kidney injury after cardiac surgery.
Phase:
Phase 2
Details
Lead Sponsor:
Region Skane
Treatments:
Epoetin Alfa